Cargando…
Identifying healthy individuals with Alzheimer’s disease neuroimaging phenotypes in the UK Biobank
BACKGROUND: Identifying prediagnostic neurodegenerative disease is a critical issue in neurodegenerative disease research, and Alzheimer’s disease (AD) in particular, to identify populations suitable for preventive and early disease-modifying trials. Evidence from genetic and other studies suggests...
Autores principales: | Azevedo, Tiago, Bethlehem, Richard A. I., Whiteside, David J., Swaddiwudhipong, Nol, Rowe, James B., Lió, Pietro, Rittman, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359360/ https://www.ncbi.nlm.nih.gov/pubmed/37474615 http://dx.doi.org/10.1038/s43856-023-00313-w |
Ejemplares similares
-
ANTsX neuroimaging-derived structural phenotypes of UK Biobank
por: Tustison, Nicholas J., et al.
Publicado: (2023) -
Structural neuroimaging measures and lifetime depression across levels of phenotyping in UK biobank
por: Harris, Mathew A., et al.
Publicado: (2022) -
Correction: Structural neuroimaging measures and lifetime depression across levels of phenotyping in UK biobank
por: Harris, Mathew A., et al.
Publicado: (2022) -
Neurological update: neuroimaging in dementia
por: Rittman, Timothy
Publicado: (2020) -
Pathway-Based Polygenic Risk Scores for Schizophrenia and Associations With Reported Psychotic-like Experiences and Neuroimaging Phenotypes in the UK Biobank
por: Barbu, Miruna C., et al.
Publicado: (2023)